This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The directors take responsibility for this announcement.
23 October 2020
SulNOx Group Plc (the "Company" or "SulNOx")
Board Changes and Suspension of Trading of Shares
(Aquis Stock Exchange: SNOX)
The Company announces the following corporate updates:
The Company announces that yesterday, 22 October 2020, it received a notice of resignation from Majken Korsgaard, non-executive director, effective immediately.
The Company also announces that Graham Lyon, non-executive chairman, will resign with immediate effect upon completion of the Annual General Meeting to be held at 12:00 today ("AGM").
Following the above resignations, and in order to ensure the Company remains in compliance with the requirements of the UK Companies Act 2006, which requires a public limited company to have at least two directors, the Board has agreed to appoint Nicholas Nelson as an executive director with effect from today. Mr Nelson is currently the Group Chief Executive Officer and was an executive director until 21 September 2020.
Suspension in trading on AQSE Growth market
As a result of the above board changes, the Company will no longer be in compliance with Rule 65 of the AQSE Growth Market Rules for Issuers, which requires an Issuer to have at least one independent non-executive director. The Company's ordinary shares of 2 pence each ("Ordinary Shares") will therefore be suspended from trading on the AQSE Growth Market prior to market opening.
The Company will make a further update following the AGM.
SulNOx Group Plc
Nicholas Nelson, Chief Executive
Media and Investors:
Flagstaff Strategic and Investor Communications
Tim Thompson / Fergus Mellon
020 7129 1474
AQSE Corporate Adviser:
Allenby Capital Limited
John Depasquale / Nick Harriss / James Hornigold
020 3328 5656
The directors take responsibility for this announcement.
This information is provided by RNS, the news service of the
. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org
or visit www.rns.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the